How much does Sotatercept-Winrevair cost? latest quote

Sotatercept-Winrevair is an innovative drug developed by Merck and was approved for marketing by the US FDA in March 2024. Its advent is considered a major breakthrough in the treatment of pulmonary arterial hypertension (PAH), because although many previous drugs can improve vasodilation, they have limited changes in the course of the disease. By targeting the inhibition of the activin signaling pathway, Sotecept can improve vascular structure and right heart function from the source, so it is highly anticipated in clinical practice.

In terms of indications, Soltercept is mainly used to treat adult patients with moderate to high-risk PAH.PAH. It is often used in combination with traditional therapies such as endothelin receptor antagonists, phosphodiesterase-5 inhibitors or prostacyclins to achieve better synergy. Overseas clinical applications have shown that patients treated with Sotecept have significantly improved exercise capacity (such as 6-minute walking distance) and cardiac function indicators, which makes it regarded as a "milestone" drug in the current treatment system.

As for the price issue, this is a common focus among patients and doctors. According to public information, the specification of Sotercept in the US market is 45mg, and the price per dose is about 69,000 yuan. Since the drug has not yet been marketed in China, it has not been included in China's medical insurance reimbursement list. Currently, domestic patients can only rely on cross-border channels if they need to use it. However, this method is not only costly, but also has practical problems such as inconvenient acquisition and long supply cycle.

It is worth noting that there are currently no generic versions of Soltercept available globally. Since this drug is a newly approved biological innovative drug, its patent protection period is still in effect, which means that its market price will not drop rapidly in the next few years. There are international predictions that if it is approved in more countries and covered by medical insurance, the price may gradually adjust.

Reference materials:https://www.drugs.com/mtm/sotatercept.html